Tamirat Koku Sisay, Leach Michael James, Papa Nathan, Millar Jeremy, Ristevski Eli
School of Rural Health, Monash University, 15 Sargeant St, Warragul, VIC, 3820, Australia.
School of Rural Health, Monash University, Bendigo, Australia.
Curr Oncol Rep. 2025 May;27(5):552-571. doi: 10.1007/s11912-025-01660-8. Epub 2025 Mar 29.
Men from culturally and linguistically diverse (CALD) backgrounds face challenges in accessing equitable and quality healthcare. However, little is known about the patterns of care among men diagnosed with prostate cancer (PCa) from CALD backgrounds. We aimed to map the available literature on patterns of care and treatment outcomes in men from CALD backgrounds who have PCa.
We used the Johanna Briggs Institute scoping review methodology. We searched five bibliographic databases (Ovid MEDLINE, EMBASE, SCOPUS, CINAHL, and Ovid Emcare) and grey literature. We explored patterns of PCa care extending from screening and early detection to end-of-life care and treatment outcomes.
A total of 7,148 records were identified; 58 studies were included. Most studies were from the United States (US) (n = 41) and used ethnic origin (n = 14), nativity (n = 10), immigration history (n = 11), or country of birth (n = 13) as indicators of CALD. Most studies focused on screening and early detection for PCa (n = 37), specifically prostate-specific antigen (PSA) testing. Twelve papers were on PCa treatment (e.g., surgery, radiation therapy, and active surveillance), five on follow-up and supportive care, and four on treatment outcomes (i.e., change in measured PSA and PCa cancer-specific survival). There were disparities in the PCa care continuum and treatment outcomes between CALD and non-CALD patients. Factors influencing screening and early detection for PCa were systematically summarised and most addressed individual-level determinants.
Key findings from our scoping review emphasised the existence of guideline-discordant care, disparities in PCa screening test use, and differences in PCa treatment received among men from CALD backgrounds. However, little is known about patterns of care in diagnostic modalities, treatment phases, and palliative and end-of-life care.
来自文化和语言背景多元（CALD）的男性在获得公平且优质的医疗保健方面面临挑战。然而，对于来自CALD背景且被诊断为前列腺癌（PCa）的男性的护理模式，我们知之甚少。我们旨在梳理关于来自CALD背景且患有PCa的男性的护理模式和治疗结果的现有文献。
我们采用了乔安娜·布里格斯研究所的范围综述方法。我们检索了五个文献数据库（Ovid MEDLINE、EMBASE、SCOPUS、CINAHL和Ovid Emcare）以及灰色文献。我们探讨了从筛查和早期检测到临终护理的PCa护理模式以及治疗结果。
共识别出7148条记录；纳入了58项研究。大多数研究来自美国（n = 41），并将种族（n = 14）、出生地（n = 10）、移民历史（n = 11）或出生国家（n = 13）用作CALD的指标。大多数研究聚焦于PCa的筛查和早期检测（n = 37），特别是前列腺特异性抗原（PSA）检测。12篇论文涉及PCa治疗（如手术、放射治疗和主动监测），5篇涉及随访和支持性护理，4篇涉及治疗结果（即测量的PSA变化和PCa癌症特异性生存率）。CALD患者和非CALD患者在PCa护理连续过程和治疗结果方面存在差异。系统总结了影响PCa筛查和早期检测的因素，且大多数涉及个体层面的决定因素。
我们范围综述的主要发现强调了存在与指南不一致的护理、PCa筛查测试使用方面的差异以及来自CALD背景的男性在接受PCa治疗方面的差异。然而，对于诊断方式、治疗阶段以及姑息和临终护理中的护理模式，我们知之甚少。
